Day 2 on Mounjaro and Still Hungry — Is That Normal?

The 2.5mg starting dose is a tolerability step, not a therapeutic target, appetite changes typically build over weeks, not days.
Tirzepatide works on two gut-hormone pathways (GIP and GLP-1) that regulate fullness; those effects take time to develop at the cellular level.
Hunger patterns on day 2 tell you very little about how well the medicine will ultimately work for you.
Eating habits, meal composition and hydration all affect how hungry you feel during the early weeks, independent of the medicine.

If you're on day 2 of Mounjaro and still hungry, you haven't done anything wrong. At 2.5mg, the starter dose is designed to help your body adjust to tirzepatide, not to suppress appetite dramatically from the outset. Most people don't notice meaningful hunger changes in the first few days — sometimes not for several weeks. That's not a sign the medicine isn't working. These are prescription-only medicines, and how and when they take effect varies between individuals; a prescriber assesses what's right for you. If you'd like to explore whether tirzepatide is the right option, you can find out more about our clinical assessment process.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What your hunger on day 2 actually tells you, and what to do about it

Why does Mounjaro take time to reduce hunger at all?

Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it activates two gut-hormone pathways involved in appetite signalling and the feeling of fullness after eating. Both of those pathways are influenced gradually as the medicine reaches a steady level in your system, and at 2.5mg, that process is only just beginning.

Think of the starter dose as your body's adjustment period, not the medicine's main event. The 2.5mg pen exists so your digestive system can adapt without being overwhelmed by nausea or other gastrointestinal side effects. Prescribers step the dose upward, typically every four weeks, until you reach the dose that actually controls your appetite. For most people in clinical trials, meaningful weight changes accumulated over months, not the first 48 hours. Our Mounjaro overview explains the full titration picture and what to expect at each stage.

The NHS patient information for tirzepatide also notes that the medicine is started at a low dose and increased slowly, which is precisely why day 2 hunger is common and expected, not a warning sign.

Is it normal to feel just as hungry on day 2 as before you started?

Yes, for the vast majority of people. The question our prescribers hear most weeks in the early phase of treatment is some version of this: it's been two days and I don't feel any different, is something wrong? Almost always, nothing is wrong.

Hunger is regulated by a complex mix of hormones, habitual meal timing, blood-sugar fluctuations and even sleep. Tirzepatide interacts with part of that system, but it doesn't override the rest of it overnight. On day one of Mounjaro, feeling unchanged is essentially universal. By day two, that's still true for most people. The medicine's appetite effects tend to become perceptible somewhere in the first few weeks, then more pronounced after the first dose increase.

If you felt no nausea, no bloating, and no change in hunger at all, that's actually a good outcome at 2.5mg. It means your body is tolerating the starting dose well, which sets you up for the steps ahead. Day 3 hunger patterns tend to look similar, and that's by design.

What can you do about hunger while the medicine builds?

A few practical things make a real difference in these early days, before the medicine's appetite effects kick in properly. Protein is the main one: meals that lead with protein and fibre slow gastric emptying and help you feel fuller for longer, which complements the mechanism tirzepatide will eventually amplify. Think eggs, Greek yoghurt, legumes, fish, foods that do some of the appetite work on their own. Our page on what to eat on Mounjaro covers this in more detail and includes guidance on keeping nutrition adequate as your appetite later changes.

Hydration matters too. Thirst and hunger signals can be difficult to tell apart, and mild dehydration is a surprisingly common reason people feel persistently peckish between meals. Aim for regular water through the day. Meal timing also helps: keeping roughly consistent eating windows prevents the sharp hunger dips that come from going too long without food, especially in the early weeks when your appetite hasn't yet been modulated by the medicine.

If you're finding it hard to know what a good food pattern looks like alongside treatment, a private service that includes aftercare gives you somewhere to ask those questions. That's worth factoring in when you're thinking about the cost of private treatment, clinical support between doses is part of what you're paying for, not an optional extra.

When should persistent hunger prompt a conversation with your prescriber?

Day 2 hunger: no action needed. But there are situations where it's worth contacting whoever is managing your treatment. If you reach the end of your first full pen (four weeks at 2.5mg) and still haven't noticed any change in appetite or fullness, that's a reasonable thing to raise before your next dose review, your prescriber may want to assess whether the dose step is appropriate or whether anything else is affecting how the medicine behaves in your body.

Similarly, if hunger is accompanied by symptoms you didn't expect (significant nausea, stomach pain, or anything that feels severe) mention it. The MHRA's Yellow Card scheme lets patients report suspected side effects directly, and your prescriber should hear about anything that concerns you. A completely smooth first week, hunger included, is far more common than problems, but the channel to report is always open.

People who are still feeling hungry on Mounjaro beyond the first couple of weeks sometimes wonder whether the medicine is working at all; that page covers what to expect as the dose increases. And if you're weighing up whether tirzepatide is the right fit, reading about the weight loss treatment options available through a clinician-led service can help you decide where to start.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions